CAR T-cell therapy – Discover Pharma

Welcome to Discover Pharma! Today is : April 28, 2026

CAR T-cell therapy

CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Clinical Trials,Regulatory Affairs
FDA clears IND amendment for automated manufacturing of Cabaletta’s rese-cel using Cellares platforms
Cellares has secured FDA clearance of an IND amendment allowing [...]

January 13, 2026
Biomanufacturing,Cell & Gene Therapy,Clinical Development,Drug Development,Technology and platforms
Trenchant BioSystems confirms AutoCell platform can cut CGT manufacturing to 2.5 days
Trenchant BioSystems has released internal and external data confirming its [...]

January 12, 2026
Clinical Development,Clinical studies,Clinical Trials,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development
CytoAgents receives fourth NIH grant to advance research on cytokine release syndrome in CAR T-cell therapy
CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]

October 7, 2025
Biomanufacturing,Biotech,Cell & Gene Therapy,Clinical Development,Pharmaceuticals and therapeutics,Research & Development
BioGrad unveils state-of-the-art Liverpool bio-manufacturing centre to drive cell and gene therapy growth in the North
BioGrad has announced plans for a new Centre of Bio-Manufacturing [...]

September 26, 2025
Cell & Gene Therapy,Patient Centricity
CAR T Vision coalition sets goal to double access to therapy by 2030
A new international alliance, CAR T Vision, launched today with [...]

May 31, 2025
Cell & Gene Therapy,Clinical Trials,Patient Centricity,Regulatory Affairs
Digital shift aims to fix long-term gaps in cell and gene therapy trials
Medable unveils a patient-first remote model to support 15-year safety [...]

May 30, 2025

main menu

recent posts

get connected

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK